What is Sopharma AD-Sofia Price-to-Free-Cash-Flow?
As of today (2024-05-16), Sopharma AD-Sofia's share price is €2.021.
Sopharma AD-Sofia's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.01. Hence, Sopharma AD-Sofia's Price-to-Free-Cash-Flow Ratio for today is 252.63.
The historical rank and industry rank for Sopharma AD-Sofia's Price-to-Free-Cash-Flow or its related term are showing as below:
During the past 13 years, Sopharma AD-Sofia's highest Price-to-Free-Cash-Flow Ratio was 560.00. The lowest was 6.73. And the median was 26.46.
FRA:3JR's Price-to-Free-Cash-Flow is not ranked *
in the Medical Distribution industry.
Industry Median: 20.26 * Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Sopharma AD-Sofia was -98.10% per year.
During the past 13 years, Sopharma AD-Sofia's highest 3-Year average Free Cash Flow per Share Growth Rate was 12.00% per year. The lowest was -36.60% per year. And the median was -12.35% per year.
Sopharma AD-Sofia Price-to-Free-Cash-Flow Historical Data
The historical data trend for Sopharma AD-Sofia's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sopharma AD-Sofia's Price-to-Free-Cash-Flow
For the Medical Distribution subindustry, Sopharma AD-Sofia's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sopharma AD-Sofia's Price-to-Free-Cash-Flow Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Sopharma AD-Sofia's Price-to-Free-Cash-Flow falls into.
Sopharma AD-Sofia's Share Price of today is €2.021. Sopharma AD-Sofia's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Sopharma AD-Sofia Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Sopharma AD-Sofia's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are organized based on the production of finished products which include Tablet dosage forms, Ampoule dosage forms, Medical products, Other forms, and Other revenue. Geographically company operates in Bulgaria and internationally.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:3JR has been successfully added to your 